Sign in to view content

Time to Dry Analysis of Brolucizumab Versus Aflibercept in Patients With Neovascular AMD: 96-Week Data From HAWK and HARRIER Trials

Carl D. Regillo, MD

Video
Published 2019

Carl D. Regillo, MD, FACS

AMD Neovascular Part I

Related

Episode 31- FLUID Study - Dr. Robyn Guymer
Keyvan Koushan, MD, FRCSC
Member Podcasts
2019
Wet AMD 5 Symposium
Annual Meeting Talks
2020
Should We Ever Consider Stopping Treatment for Neovascular AMD?
Rahul N. Khurana, MD, FASRS
Updates from the Field
2020

Category: AMD-Neovascular

See more